Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults
Clinical trial NCT03478891 · COMPLETED
Trial details
- NCT number
- NCT03478891
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-16
- Primary completion
- 2019-03-20
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.